Raymond James Financial Services Advisors, Inc. Evolus, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$3.03 - $5.48 $53,106 - $96,047	-17,527 Closed	0 $0
Q2 2020 Jul 17, 2020	SELL	$3.53 - $6.17 $3,607 - $6,305	-1,022 Reduced 5.51%	17,527 $93,000
Q1 2020 Apr 21, 2020	BUY	$3.53 - $12.21 $10,762 - $37,228	3,049 Added 19.67%	18,549 $77,000
Q4 2019 Feb 12, 2020	SELL	$11.58 - $17.37 $215,353 - $323,029	-18,597 Reduced 54.54%	15,500 $189,000
Q3 2019 Nov 07, 2019	SELL	$13.91 - $19.87 $36,277 - $51,820	-2,608 Reduced 7.11%	34,097 $533,000
Q2 2019 Aug 06, 2019	SELL	$13.19 - $28.36 $280,762 - $603,670	-21,286 Reduced 36.71%	36,705 $537,000
Q1 2019 May 06, 2019	BUY	$12.43 - $28.91 $720,828 - $1.68 Million	57,991 New	57,991 $1.31 Million
Q4 2018 Feb 11, 2019	SELL	$10.57 - $19.29 $119,747 - $218,536	-11,329 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$17.31 - $29.82 $9,018 - $15,536	521 Added 4.82%	11,329 $211,000
Q2 2018 Jul 30, 2018	BUY	$6.85 - $38.49 $74,034 - $415,999	10,808 New	10,808 $303,000

Others Institutions Holding EOLS

# of Institutions

169

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

Perceptive Advisors LLC New York, NY

5.36M
Shares

$64.5 Million
2.27% of portfolio
Tang Capital Management LLC San Diego, CA

4.85M
Shares

$58.4 Million
6.69% of portfolio
Black Rock Inc. New York, NY

4.01M
Shares

$48.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.2M
Shares

$38.5 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.82M
Shares

$34 Million
2.72% of portfolio

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $675M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account